TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Prepaid Expenses, Other
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Prepaid Expenses, Other of $381.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2021-09-28
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expenses, other for fiscal 2021 was $381.00K, a 545.76% increase from fiscal 2020.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in prepaid expenses, other for fiscal 2020 was $59.00K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|
| 2021-06-30 | $381.00K 10-K · filed 2021-09-28 |
| 2020-06-30 | $59.00K 10-K · filed 2021-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |